[Evaluation of the efficacy and safety of the neuroprotective complex Neurouridin in patients with back pain].

Autor:	Yakupov EZ; Kazan State Medical University, Kazan, Russia.; Scientific research Medical Complex «Your Health», Kazan, Russia., Troshina YV; Kazan State Medical University, Kazan, Russia.; Scientific research Medical Complex «Your Health», Kazan, Russia., Gainutdinova RR; Kazan State Medical University, Kazan, Russia.; Scientific research Medical Complex «Your Health», Kazan, Russia., Kashapova AO; Scientific research Medical Complex «Your Health», Kazan, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2021; Vol. 121 (6), pp. 46-51.
DOI:	10.17116/jnevro202112106146
Abstrakt:	Objective: To study the efficacy and safety of the neurouridin dietary supplement in patients with back pain. Material and Methods: The study included 3179 patients with low back pain. Patients were randomized into the main group and the comparison group who did not receive neurouridin. The Visual Analogue scale (VAS), the Roland-Morris Questionnaire (RMQ) and The Clinical Global Impression (CGI) scale were used. Results and Conclusion: A positive effect of treatment on VAS scores and a greater degree of decrease in the intensity of pain was observed in the main group compared with the comparison group. Signs of improved functional status according to RMQ and CGI are shown.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu